Hereditary Transthyretin Amyloidosis (HATTR) Market Report

Global and China Hereditary Transthyretin Amyloidosis (HATTR) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 16, 2022
  • PAGES：142
  • REPORT CODE：GMM1379305
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Hereditary Transthyretin Amyloidosis (HATTR) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Lonis Pharmaceuticals

    • Eidos Therapeutics

    • Alnylam Pharmaceuticals

    • Prothena

    • Corino Therapeutics Inc

    • Pfizer

    • Akcea Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Subcutaneous Injection

    • Others

    Application:

    • Hospital

    • Clinic

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Overview

      • 1.1.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Scope and Market Segments

      • 1.1.2 Hereditary Transthyretin Amyloidosis (HATTR) Industry Characteristics

      • 1.1.3 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Subcutaneous Injection

      • 1.2.3 Others

    • 1.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Industry PEST Analysis

    • 2.3 Hereditary Transthyretin Amyloidosis (HATTR) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hereditary Transthyretin Amyloidosis (HATTR) Industry

    Chapter 3 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market, by Manufacturer

    • 3.1 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market Top 3 Players

    Chapter 4 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type (2017-2028)

    • 4.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Trend, by Type

    • 4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Price Trend, by Type (2017-2028)

    • 4.3 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hereditary Transthyretin Amyloidosis (HATTR) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis

    • 7.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type

    • 7.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application

    • 7.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Forecast, by Country

      • 7.3.1 United States Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis

    • 8.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type

    • 8.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application

    • 8.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis

    • 9.1 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type

    • 9.2 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application

    • 9.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Forecast, by Country

      • 9.3.1 China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis

    • 10.1 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type

    • 10.2 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application

    • 10.3 Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hereditary Transthyretin Amyloidosis (HATTR) Company Profiles

      • 11.1 Lonis Pharmaceuticals

        • 11.1.1 Lonis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.1.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eidos Therapeutics

        • 11.2.1 Eidos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.2.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Alnylam Pharmaceuticals

        • 11.3.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.3.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Prothena

        • 11.4.1 Prothena Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Corino Therapeutics Inc

        • 11.5.1 Corino Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.5.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.6.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Akcea Therapeutics

        • 11.7.1 Akcea Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Profiles, Application and Specification

        • 11.7.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hereditary Transthyretin Amyloidosis (HATTR) Industry Investment Prospect and Risk Assessment

    • 12.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hereditary Transthyretin Amyloidosis (HATTR) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Production Value and Growth Rate (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Production Value and Growth Rate (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Subcutaneous Injection (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market Share, by Manufacturer in 2021

    • Figure Global and China Hereditary Transthyretin Amyloidosis (HATTR) Market Share, by Manufacturer in 2022

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Type (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Type (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Price Trend, by Type (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Type (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Type (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Price Trend, by Type (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Application (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Application (2017-2028)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Application (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, by Application (2017-2028)

    • Table China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Application (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Share, by Application (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Production, Import, Consumption and Export (2017-2022)

    • Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure United States Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure UK Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure France Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure France Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Table APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure India Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure India Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hereditary Transthyretin Amyloidosis (HATTR) Sales Value and Growth Rate (2017-2028)

    • Table Lonis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lonis Pharmaceuticals Product Profiles, Application and Specification

    • Table Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eidos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eidos Therapeutics Product Profiles, Application and Specification

    • Table Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Prothena Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Prothena Product Profiles, Application and Specification

    • Table Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Corino Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Corino Therapeutics Inc Product Profiles, Application and Specification

    • Table Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Akcea Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Akcea Therapeutics Product Profiles, Application and Specification

    • Table Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US